↓ Skip to main content

Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa

Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs
1 blog
twitter
19 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa
Published in
Journal of Antimicrobial Chemotherapy (JAC), July 2022
DOI 10.1093/jac/dkac241
Pubmed ID
Authors

Cristina Lasarte-Monterrubio, Pablo Arturo Fraile-Ribot, Juan Carlos Vázquez-Ucha, Gabriel Cabot, Paula Guijarro-Sánchez, Isaac Alonso-García, Soraya Rumbo-Feal, Fátima Galán-Sánchez, Alejandro Beceiro, Jorge Arca-Suárez, Antonio Oliver, Germán Bou

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 15%
Other 4 12%
Researcher 4 12%
Lecturer 1 3%
Student > Bachelor 1 3%
Other 3 9%
Unknown 15 45%
Readers by discipline Count As %
Medicine and Dentistry 5 15%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 3 9%
Nursing and Health Professions 1 3%
Agricultural and Biological Sciences 1 3%
Other 2 6%
Unknown 18 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2023.
All research outputs
#1,936,795
of 25,411,814 outputs
Outputs from Journal of Antimicrobial Chemotherapy (JAC)
#623
of 8,180 outputs
Outputs of similar age
#41,836
of 432,167 outputs
Outputs of similar age from Journal of Antimicrobial Chemotherapy (JAC)
#10
of 88 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,180 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,167 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.